Ozmosi | Phenindione Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Phenindione

Alternative Names: phenindione, hedulin
Clinical Status: Inactive
Latest Update: 2021-05-24
Latest Update Note: Clinical Trial Update

Product Description

Phenindione is a beta-diketone and an aromatic ketone. It has a role as an anticoagulant.  (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Phenindione)

Mechanisms of Action: Vitamin K Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Approved

Approved Countries: Australia | Malta | Russia | Taiwan | Ukraine | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Bayer
Company Location:
Company CEO: Werner Baumann
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Atrial Fibrillation|Stroke|Pregnancy Outcomes|Atrial Flutter|Ventricular Flutter|Intracranial Hemorrhages|Ventricular Fibrillation|Subarachnoid Hemorrhage|Cerebral Small Vessel Diseases|Cerebral Hemorrhage|Hematoma, Subdural, Intracranial|Intracranial Hemorrhage, Hypertensive|Cerebrovascular Disorders

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT04099238

BEST-AF

N/A

Completed

Atrial Fibrillation

2020-07-16

2020-08-08

2016-004121-16

Start or STop Anticoagulants Randomised Trial (SoSTART)

P3

Unknown status

Atrial Fibrillation|Stroke

2022-09-11

2022-03-13

Treatments

NCT03153150

SoSTART

P3

Completed

Cerebral Small Vessel Diseases|Intracranial Hemorrhages|Cerebral Hemorrhage|Subarachnoid Hemorrhage|Atrial Fibrillation|Ventricular Flutter|Cerebrovascular Disorders|Hematoma, Subdural, Intracranial|Atrial Flutter|Ventricular Fibrillation|Intracranial Hemorrhage, Hypertensive

2021-03-26

2021-05-25

Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status

NCT01758640

AINSHAMS2012

P3

Completed

Pregnancy Outcomes

2012-06-01

2019-03-19

Treatments

Recent News Events